Dr. Burwick specializes in treating plasma cell disorders including MGUS, multiple myeloma, Waldenstromâs macroglobulinemia, and amyloidosis.
My philosophy is that all patients should receive high quality comprehensive care, with access to the state of the art clinical trial options. I have a strong belief in understanding disease biology and using this knowledge to inform personalized treatment decisions.
Plasma cell disorders including MGUS, Multiple Myeloma, Waldenstrom’s Macroglobulinemia, Amyloidosis
Acting Instructor, Hematology Division, University of Washington School of Medicine
- MD: Duke University School of Medicine
- Fellowship: University of Washington/Fred Hutchinson Cancer Research Center, Hematology/Oncology
- Residency: Beth Israel Deaconess Medical Center (Boston)
- Research Fellowship in Multiple Myeloma: Dana Farber Cancer Institute